Cancer Pharma Industry

The cancer drugs market is driven by the growing prevalence of various types of cancer, increasing demand of biological and targeted drug therapies, continuous patent expiry of key cancer drugs and the rising impact of biosimilars. However, the high cost of drug development, the threat of failure and the adverse effects of cancer drug therapy, particularly chemotherapy, hinders the market growth. Advancement of cancer drug research owing to biological/targeted therapies and personalized medicines hold promising opportunities for pharmaceutical, bio-pharmaceutical and biotechnology companies engaged in developing cancer drugs.

    Related Conference of Cancer Pharma Industry

    November 19-20, 2026

    44th World Cancer Conference

    Dubai, UAE
    November 23-24, 2026

    8th International Conference on Women Oncology

    Miami, USA
    November 23-24, 2026

    7th Cancer Diagnostics & Treatment Conference

    Miami, USA
    November 24-25, 2026

    6th International Conference on Oncology and Cancer

    Paris, France
    December 03-04, 2026

    10th Global Meeting on Oncology and Radiology

    Madrid, Spain
    December 08-09, 2026

    14th Euro Breast Cancer and Therapeutics

    Paris, France
    December 08-09, 2026

    27th World Congress on Cancer Summit

    Paris, France
    February 15-16, 2027

    5th World Congress on Oral Cancer

    Singapore City, Singapore
    April 15-16, 2027

    12th World Conference on Breast and Cervical Cancer

    Amsterdam, Netherlands
    April 27-28, 2027

    37th Experts Meet On Cancer Research & Therapy

    Paris, France
    May 05-06, 2027

    7th World Congress on Breast Cancer

    Berlin, Germany
    May 05-06, 2027

    23rd International Conference on Cancer Research

    Berlin, Germany

    Cancer Pharma Industry Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in